Hint | Answer | % Correct |
---|---|---|
what is the one anticholinergic drug used in Australia to treat asthma? | ipratropium | 100%
|
ipratropium | 100%
| |
what are the nasal decongestants used to treat allergic rhinitis? | phenylephrine | 100%
|
pseudoephedrine | 100%
| |
what are the types of antihistamines used to treat allergic rhinitis? | 1st generation | 75%
|
2nd generation | 75%
| |
act on central H1 receptors | 75%
| |
what is omalizumab used to treat? | allergic asthma | 75%
|
allergic rhinitis | 75%
| |
what kind of molecule is omalizumab? | a recombinant-derived monoclonal antibody | 75%
|
what is the mechanism of action of each of these? | blocks the generation of leukotrienes from arachidonic acid by inhibiting 5-lipoxygenase | 75%
|
codeine | 75%
| |
corticosteroids | 75%
| |
what are the drugs that treat cough? | dextromethorphan | 75%
|
what is an example of a corticosteroid used to treat asthma? | fluticasone, prednisolone, etc | 75%
|
what is its mechanism of action? | it binds to immunoglobulin E (IgE) and reduces binding of IgE to its receptor on the surface of basophils, mast cells and dendritic cells | 75%
|
what does this do to mast cells? | it limits the degranulation of mast cells, thereby reducing release of pro-inflammatory mediators involved in the allergic response | 75%
|
long acting | 75%
| |
loratadine, fexophenadine, etc | 75%
| |
what kind of drugs are cromolyn & nedocromil? | mast cell stabilisers | 75%
|
monteleukast, zafirleukast, & pranleukast | 75%
| |
pholcodine | 75%
| |
what is their mechanism of action? | phosphodiesterase inhibitors: competitive enzyme inhibition results in sustained elevation of cAMP or cGMP resulting in bronchodilation | 75%
|
what do they do? | prevent the release of inflammatory mediators such as histamine | 75%
|
what is an example of each? | salbutamol, terbutaline, etc | 75%
|
salmetrol, bambuterol, etc | 75%
| |
what receptors do they act on? | selective for peripheral H1 receptors | 75%
|
what are the 3 types of sympathomimetics used to treat asthma? | short acting | 75%
|
what is an example? | theophylline, aminophylline | 75%
|
what is their mechanism of action? | they act on peripheral H1 histamine receptors (in mast cells, endothelium and smooth muscle) to reduce the symptoms of allergic rhinitis | 75%
|
what is their mechanism of action? | they are a1-adrenergic receptor agonists that cause vasoconstriction and increase mucociliary clearance, therefore decreasing airway resistance | 75%
|
thought to activate μ and k opioid receptors in the cough centre of the brain | 75%
| |
thought to activate μ and k opioid receptors in the cough centre of the brain | 75%
| |
what are the leukotriene antagonists used to treat asthma? | zileuton | 75%
|
what is their mechanism of action? | activation of b2 receptors relaxes smooth muscle in the airways (bronchodilation), without affecting inflammation | 50%
|
what drugs are used to treat COPD? | b-adrenergic agonists | 50%
|
what are their postulated mechanisms of action? | binds to sigma receptors in the cough centre of the brain | 50%
|
carmoterol, indacaterol, etc | 50%
| |
what is an example of these? | chlorphenamine, mepyramine, etc | 50%
|
what kind of drugs are xanthines? | naturally occurring stimulants | 50%
|
what is their mechanism of action? | they bind to the glucocorticoid receptor to up-regulate expression of several anti-inflammatory proteins as well as down-regulate pro-inflammatory proteins | 50%
|
they inhibit cysteinyl leukotriene receptor 1 (cysLT1), blocking the action of leukotriene D4 | 50%
| |
what is its mechanism of action? | works as a non-selective muscarinic receptor antagonist to: - decrease Ach-mediated bronchospasms - reduce irritant-induced mucus secretion - increase ciliary clearance | 50%
|
ultra long acting | 25%
|
Copyright H Brothers Inc, 2008–2024
Contact Us | Go To Top | View Mobile Site